ERBB2 and breast carcinoma: MDA-MB-453 cancer cell line was chosen as the breast cancer model as it is a triple negative cell line having ER–/AR+ phenotype and it was experimentally verified that Her2 expression is not there in MDA-MB-453 cells by IHC staining (Fig. 2A).